Elke Pogge von Strandmann
Laboratory of Immunotherapy
Department I for Internal Medicine
University Hospital of Cologne
Kerpener Str 62
Germany
Name/email consistency: high
- A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo. von Strandmann, E.P., Hansen, H.P., Reiners, K.S., Schnell, R., Borchmann, P., Merkert, S., Simhadri, V.R., Draube, A., Reiser, M., Purr, I., Hallek, M., Engert, A. Blood (2006)